E0

Skin Cancer AI Has Crossed a Line: It Is Discharging Patients on Its Own
A real-world NHS study of more than 8,000 urgent suspected skin-cancer referrals suggests autonomous AI can safely remove many benign lesions from the specialist queue and release thousands of appointments. That makes post-market surveillance—not hype—the central issue.

Parkinson’s Is Trying to Vaccinate Against Progression

One Psychedelic Dose Is Now a Phase III Argument

Menstrual Migraine Was Never Just Regular Migraine

MS Gets a Cleaner BTK Signal

Virtual reality may solve one of cardiac imaging’s most overlooked barriers

Obesity drugs may move beyond appetite suppression. Moonwalk just raised $70 million to target fat tissue directly

Sanfilippo’s Approval Path Is Being Built Before Approval

Myositis Finally Gets a Targeted Signal

Anxiety Gets a Psychedelic Trial, Not a Shortcut
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
